Ethicon’s decision to pull its Physiomesh surgical mesh off the market earlier this year is just one more in a string of failures for the medical device unit of Johnson & Johnson. The decision comes from mounting evidence of a higher number of revision surgeries associated with Physiomesh than with other similar surgical mesh devices.
Data compiled from two separate hernia registries showed ...
continue reading...